Show simple item record

dc.contributor.authorDal Ponte, Silvana Teixeirapt_BR
dc.contributor.authorAlegretti, Ana Paulapt_BR
dc.contributor.authorRezende, Gabriela Petitotpt_BR
dc.contributor.authorAndrioli, Giordanna Guerrapt_BR
dc.contributor.authorDiogo, Luciano Passamanipt_BR
dc.contributor.authorGoldani, Luciano Zubaranpt_BR
dc.contributor.authorMachado, Pauline Simaspt_BR
dc.contributor.authorSeligman, Renatopt_BR
dc.date.accessioned2016-07-19T02:17:41Zpt_BR
dc.date.issued2015pt_BR
dc.identifier.issn2381-2729pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/143678pt_BR
dc.description.abstractSepsis is a systemic inflammatory response against suspected or documented infection. In an infectious process, inflammation is triggered activating leukocytes, mainly neutrophils. CD64 is a surface antigen weakly expressed on non-activated mature neutrophils. When neutrophil CD64 is strongly expressed on neutrophils, it means neutrophils were activated, thus suggesting the presence of bacterial infection or acute fungal infection. A large number of biological substances has been investigated as candidate biomarkers and/or mediators of sepsis. Recent studies have focused on the investigation of neutrophil CD64 as a possible biomarker for the diagnosis of sepsis.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofJacobs journal of biomarkers. Austin. Vol. 1, no. 2 (Aug. 2015), p. 010, [8] p.pt_BR
dc.rightsOpen Accessen
dc.subjectSepsisen
dc.subjectNeutrófilospt_BR
dc.subjectSepsept_BR
dc.subjectSIRSen
dc.subjectBiomarcadorespt_BR
dc.subjectCD64en
dc.subjectBiomarkeren
dc.titleReview of the literature : sepsis and neutrophil Cd64pt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000992658pt_BR
dc.type.originEstrangeiropt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record